Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting

Katherine R McAleese; Janitzio J Guzmán; Lauren Thumm; Thomas B Nutman; Adrienne Showler; Elise M O'Connell

doi:10.1093/cid/ciac076

Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting

Clin Infect Dis. 2022 Sep 14;75(5):897-900. doi: 10.1093/cid/ciac076.

Authors

Katherine R McAleese¹, Janitzio J Guzmán², Lauren Thumm², Thomas B Nutman², Adrienne Showler^{2

3}, Elise M O'Connell²

Affiliations

¹ Department of Internal Medicine and Pediatrics, MedStar Georgetown University Hospital, Washington, D.C., USA.
² Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
³ Department of Infectious Disease and Tropical Medicine, MedStar Georgetown University Hospital, Washington, D.C., USA.

Abstract

In a cohort of mostly Central American immigrants with confirmed neurocysticercosis (NCC), 3.1% were confirmed positive for Chagas disease (CD). The majority were diagnosed with NCC before age 50. Entry to care for NCC is an opportunity for early detection and possible treatment for CD in those from endemic areas.

Keywords: Chagas disease; neurocysticercosis; screening.

Published by Oxford University Press for the Infectious Diseases Society of America 2022.

Publication types

Research Support, N.I.H., Intramural

MeSH terms

Chagas Disease* / diagnosis
Chagas Disease* / epidemiology
Cohort Studies
Emigrants and Immigrants*
Humans
Middle Aged
Neurocysticercosis* / diagnosis
Neurocysticercosis* / epidemiology
Prevalence